Formosa Pharmaceutical and Sarval Corporation announced licensing agreement for the Suspension of Cletasolol in Ophthalmic Suspension for the treatment of post-operative disease




Formosa Pharmaceutical and Sarval Corporation announced licensing agreement for the Suspension of Cletasolol in Ophthalmic Suspension for the treatment of post-operative disease



Source link

  • Related Posts

    Client Challenge

    Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to continue. A required part of this site could not load. This could be due to a browser extension,…

    OpenAI in talks for $10m Amazon investment and chip deal – report

    OpenAI in talks for $10m Amazon investment and chip deal – report Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *